News provided by Hanmi Pharmaceutical Jan 27, 2026, 23:08 ET Hanmi Signs Exclusive Partnership with New Mexican Partner Laboratorios Sanfer, Covering Efpeglenatide and Diabetes Treatments SEOUL, South Korea, Jan
IBS and Bile Acid Diarrhea Irritable bowel syndrome with diarrhea predominance keeps transit chronically fast
PHIL: There's all kinds of different options
The detoxification enzyme systems
Storage requirements Retatrutide stability depends heavily on proper storage at every stage
The lowest dose of orforglipron resulted in less than 8 percent loss of body weight, or about 18 pounds, and the middle dose led to a 9 percent reduction, or 21 pounds